Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents

IntroductionThe novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been posing a severe threat to global public health. Although broadly neutralizing antibodies have been used to prevent or treat corona virus disease 2019 (COVID-19), new emerging variants have been prove...

Full description

Bibliographic Details
Main Authors: Zheng Wang, Dan Li, Yulu Chen, Yeping Sun, Changzhong Jin, Caiqin Hu, Yi Feng, Junwei Su, Li Ren, Yanling Hao, Shuo Wang, Meiling Zhu, Ying Liu, Jianxun Qi, Biao Zhu, Yiming Shao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
receptor binding domain
neutralizing antibody
antibody-antigen complex
antibodyome
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1160283/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1160283/full

Similar Items